Amgen Inc Stock Short Ratio
AMGN Stock | USD 284.32 1.98 0.69% |
Amgen Inc fundamentals help investors to digest information that contributes to Amgen's financial success or failures. It also enables traders to predict the movement of Amgen Stock. The fundamental analysis module provides a way to measure Amgen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amgen stock.
Amgen | Short_Ratio |
Amgen Short Ratio Analysis
Amgen's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
More About Short_Ratio | All Equity Analysis
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 1.2B | 1.4B | 2.9B | 3.0B | Depreciation And Amortization | 3.4B | 3.4B | 4.1B | 4.3B |
Short Ratio | = | Short InterestAverage Trading Volume |
Current Amgen Short Ratio | 3.52 X |
Most of Amgen's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amgen Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Amgen Short Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Amgen is extremely important. It helps to project a fair market value of Amgen Stock properly, considering its historical fundamentals such as Short Ratio. Since Amgen's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Amgen's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Amgen's interrelated accounts and indicators.
Click cells to compare fundamentals
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Competition |
Amgen Short Term Coverage Ratios
Short Term Coverage Ratios |
|
Based on the latest financial disclosure, Amgen Inc has a Short Ratio of 3.52 times. This is 9.74% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The short ratio for all United States stocks is 12.0% higher than that of the company.
Amgen Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amgen's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amgen could also be used in its relative valuation, which is a method of valuing Amgen by comparing valuation metrics of similar companies.Amgen is currently under evaluation in short ratio category among related companies.
Amgen ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Amgen's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Amgen's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Amgen Institutional Holders
Institutional Holdings refers to the ownership stake in Amgen that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Amgen's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Amgen's value.Shares | Northern Trust Corp | 6.4 M | Royal Bank Of Canada | 2023-12-31 | 5.8 M | Bank Of New York Mellon Corp | 2023-12-31 | 5.5 M | Norges Bank | 2023-12-31 | 5.4 M | Legal & General Group Plc | 2023-12-31 | 5 M | Fmr Inc | 2023-12-31 | 4.8 M | Bank Of America Corp | 2023-12-31 | 4.3 M | Aristotle Capital Management Llc | 2023-12-31 | 4.2 M | Jpmorgan Chase & Co | 2023-12-31 | 4 M | Vanguard Group Inc | 2023-12-31 | 49 M | Blackrock Inc | 2023-12-31 | 47.8 M |
Amgen Fundamentals
Return On Equity | 1.36 | ||||
Return On Asset | 0.0629 | ||||
Profit Margin | 0.24 % | ||||
Operating Margin | 0.08 % | ||||
Current Valuation | 207.11 B | ||||
Shares Outstanding | 535.92 M | ||||
Shares Owned By Insiders | 0.24 % | ||||
Shares Owned By Institutions | 80.90 % | ||||
Number Of Shares Shorted | 11.11 M | ||||
Price To Earning | 22.74 X | ||||
Price To Book | 24.62 X | ||||
Price To Sales | 5.44 X | ||||
Revenue | 28.19 B | ||||
Gross Profit | 19.92 B | ||||
EBITDA | 7.9 B | ||||
Net Income | 6.72 B | ||||
Cash And Equivalents | 11.48 B | ||||
Cash Per Share | 21.51 X | ||||
Total Debt | 64.61 B | ||||
Current Ratio | 1.68 X | ||||
Book Value Per Share | 11.64 X | ||||
Cash Flow From Operations | 8.47 B | ||||
Short Ratio | 3.52 X | ||||
Earnings Per Share | 12.48 X | ||||
Price To Earnings To Growth | 2.56 X | ||||
Target Price | 308.5 | ||||
Number Of Employees | 26.7 K | ||||
Beta | 0.58 | ||||
Market Capitalization | 153.43 B | ||||
Total Asset | 97.15 B | ||||
Retained Earnings | (26.55 B) | ||||
Working Capital | 11.94 B | ||||
Current Asset | 38.52 B | ||||
Current Liabilities | 8.67 B | ||||
Z Score | 1.75 | ||||
Annual Yield | 0.03 % | ||||
Five Year Return | 2.82 % | ||||
Net Asset | 97.15 B | ||||
Last Dividend Paid | 8.52 |
About Amgen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amgen Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amgen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amgen Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 24200 people.
Amgen Investors Sentiment
The influence of Amgen's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Amgen. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Amgen's public news can be used to forecast risks associated with an investment in Amgen. The trend in average sentiment can be used to explain how an investor holding Amgen can time the market purely based on public headlines and social activities around Amgen Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Amgen's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Amgen's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Amgen's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Amgen.
Amgen Implied Volatility | 20.28 |
Amgen's implied volatility exposes the market's sentiment of Amgen Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Amgen's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Amgen stock will not fluctuate a lot when Amgen's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amgen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amgen's short interest history, or implied volatility extrapolated from Amgen options trading.
Pair Trading with Amgen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amgen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will appreciate offsetting losses from the drop in the long position's value.Moving together with Amgen Stock
0.62 | MBIO | Mustang Bio Report 3rd of April 2024 | PairCorr |
Moving against Amgen Stock
0.79 | EQ | Equillium Financial Report 9th of May 2024 | PairCorr |
0.65 | DNLI | Denali Therapeutics Financial Report 13th of May 2024 | PairCorr |
0.6 | MDWD | Mediwound Downward Rally | PairCorr |
0.58 | MDGL | Madrigal Pharmaceuticals Financial Report 14th of May 2024 | PairCorr |
0.51 | YS | YS Biopharma Report 22nd of April 2024 | PairCorr |
The ability to find closely correlated positions to Amgen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amgen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amgen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amgen Inc to buy it.
The correlation of Amgen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amgen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Amgen Piotroski F Score and Amgen Altman Z Score analysis. Note that the Amgen Inc information on this page should be used as a complementary analysis to other Amgen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Amgen Stock analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Amgen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.52) | Dividend Share 8.52 | Earnings Share 12.48 | Revenue Per Share 52.692 | Quarterly Revenue Growth 0.198 |
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.